Table 4 Median healthcare resource use for managing acute exacerbations and follow-up of patients with IPF
Acute exacerbation and follow-up | Management and follow-up of patients with IPF (over a 3-month period) | |||
|---|---|---|---|---|
Stable disease | Slow disease progression | Rapid disease progression | ||
Outpatient visits | ||||
General practitioner home visits | 0.2 | 0.0 | 0.0 | 0.0 |
Pulmonary specialist | 2.0 | 1.0 | 1.0 | 2.0 |
Nurse (or other healthcare professional) | 0.6 | 0.0 | 0.0 | 0.0 |
Elective ambulance | 0.3 | 0.0 | 0.0 | 0.0 |
Emergency | ||||
Emergency room visits | 1.0 | 0.0 | 0.0 | 1.0 |
Emergency ambulance | 0.8 | 0.0 | 0.0 | 0.0 |
Hospital admissions | ||||
Pulmonary department (days) | 11.3 | 0.0 | 0.0 | 7.5 |
Intensive care unit (days) | 2.5 | 0.0 | 0.0 | 0.8 |
Laboratory tests | ||||
Complete blood count | 3.0 | 1.0 | 1.0 | 1.0 |
Sedimentation rate | 2.0 | 0.0 | 1.0 | 1.0 |
Liver profile | 2.0 | 0.0 | 1.0 | 1.0 |
Creatine phosphokinase | 1.5 | 0.0 | 0.0 | 1.0 |
Urinalysis | 0.2 | 0.0 | 0.0 | 0.0 |
Microbiology | 0.1 | 0.0 | 0.0 | 0.0 |
Respiratory function tests | ||||
Spirometry | 1.0 | 1.0 | 1.0 | 1.0 |
Body plethysmography | 0.1 | 0.0 | 1.0 | 1.0 |
Diffusing capacity of carbon monoxide | 1.0 | 0.0 | 1.0 | 1.0 |
6-min walk test | 0.3 | 0.0 | 1.0 | 1.0 |
Other tests | ||||
Chest X-ray | 3.0 | 0.0 | 0.5 | 1.0 |
High-resolution computed tomography | 1.0 | 0.0 | 0.0 | 1.0 |
Blood gases | 3.0 | 0.0 | 0.3 | 1.5 |
Computed tomography pulmonary angiogram | 0.3 | 0.0 | 0.0 | 0.0 |
Bronchoscopy | 0.3 | 0.0 | 0.0 | 0.0 |
Sputum assessment | 0.8 | 0.0 | 0.0 | 0.0 |
Bronchoalveolar lavage | 0.2 | 0.0 | 0.0 | 0.0 |